The short version of 合成肽 fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-11-27 and is reviewed periodically as new material appears.
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 44-residue peptide | GHRH analog backbone |
| Approximate molecular mass | 5136 Da | Varies with counterion and hydration state |
| N-terminal group | trans-3-hexenoyl | Increases resistance to dipeptidyl peptidase IV |
| Primary receptor | GHRH receptor (GHRHR) | Class B G protein-coupled receptor on somatotrophs |
| Principal mediator | IGF-1 | Rises indirectly after growth hormone release |
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone (GHRH) family. Its sequence corresponds to the fully active 44-amino-acid form of human GHRH, with a single structural modification: the addition of a trans-3-hexenoyl group at the N-terminus. That modification is not found in the naturally occurring hormone and was introduced deliberately during development to improve stability against enzymatic degradation. The compound is therefore best described as a stabilized analogue rather than a naturally occurring peptide.
The native hormone is produced in the hypothalamus and acts on the anterior pituitary. Binding of GHRH to its receptor stimulates synthesis and release of growth hormone into circulation. Because the analogue retains the receptor-binding region of the parent sequence, it engages the same receptor and triggers the same downstream signaling. The result is increased growth hormone secretion from pituitary cells, which in turn influences hepatic production of insulin-like growth factor 1. This axis is the basis for the compound's measured biological effects.
在临床研究之外，特沙莫瑞林常被讨论为生长激素分泌促进剂，但这一说法需要限定。它并不等同于生长激素本身，也不属于普通减重药物。部分研究关注其减少腹部脂肪和改善脂质谱的潜力，另一些研究则关注胰岛素抵抗和 IGF-1 升高等信号。这些效应的临床意义仍在评估中，尚未形成统一结论。
特沙莫瑞林是一种合成肽，其序列与人生长激素释放激素的 44 个氨基酸形式相关。它在 N 端带有反式-3-己烯酰基修饰，这一改动可减缓二肽基肽酶 IV 的降解。该化合物属于生长激素释放激素受体激动剂，可刺激垂体释放生长激素。研究文献通常将其归入合成肽类药物，而非小分子化合物。
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
== AUC and bioavailability == In pharmacokinetics, bioavailability generally refers to the fraction of a drug that is absorbed systemically and is thus available to produce a biological effect. This is often measured by quantifying the "AUC". In order to determine the respective AUCs, the serum concentration vs. time plots are typically gathered using C-14 labelled drugs and AMS (accelerated mass spectrometry). Bioavailability can be measured in terms of "absolute bioavailability" or "relative bioavailability".
=== Logo and mascot === The club's current logo was introduced in 1998, making it the oldest AFL logo in use. Their mascot is known as "Skeeta Reynolds", and was named after Dick Reynolds. He is a mosquito and was created in honour of the team's back-to-back premiership sides in the 1920s known as the "Mosquito Fleet". He was first named through a competition run in the Bomber magazine with "Skeeta" being the winning entry. This was later changed to "Skeeta Reynolds". He appears as a red mosquito in an Essendon jumper and wears a red and black scarf.
=== Mechanical properties === α-Helices under axial tensile deformation, a characteristic loading condition that appears in many alpha-helix-rich filaments and tissues, results in a characteristic three-phase behavior of stiff-soft-stiff tangent modulus. Phase I corresponds to the small-deformation regime during which the helix is stretched homogeneously, followed by phase II, in which alpha-helical turns break mediated by the rupture of groups of H-bonds. Phase III is typically associated with large-deformation covalent bond stretching.
== Further reading == Gustavo V. Barbosa-Canovas, Liliana Alamilla-Beltran, Efren Parada-Arias, Jorge Welti-Chanes (2015) Water Stress in Biological, Chemical, Pharmaceutical and Food Systems. New York, NY : Springer New York : Imprint: Springer. ISBN 978-1-4939-2578-0 Jamuna Aswathanarayn & Rai, V. Ravishankar (2015). Microbial Food Safety and Preservation Techniques. Boca Raton : CRC Press Taylor & Francis Group. ISBN 9781138033801
== Surveillance == Comparitech Limited, a UK technology advisor, published "The world's most-surveilled cities" in August 2019. It assembled data on the number of closed-circuit television (CCTV) cameras installed in 120 global cities. It then ranked the cities by number of cameras per 1,000 inhabitants. China's cities were found to be the most surveilled. Bangkok was ranked 31 (1=most surveilled; 120=least surveilled), with an estimated 53,429 cameras installed, or 5.16 cameras per 1,000 inhabitants. Other ASEAN cities were ranked: Singapore, 11 (86,000 cameras); Ho Chi Minh City, 72 (6,150 cameras); Yangon, 76 (2,995 cameras); Jakarta, 77 (6,000 cameras); Hanoi, 79 (4,400 cameras); Kuala Lumpur, 106, (1,000 cameras).
Sources: en.wikipedia.org
=== Aminoacyl-tRNA synthetase === Each of the 20 amino acids are recognized by its specific aminoacyl-tRNA synthetase. The synthetases are usually composed of one to four protein subunits. The enzymes vary considerably in structure although they all perform the same type of reaction by binding ATP, one specific amino acid and its corresponding tRNA. The most important activity of the aminoacyl-tRNA synthetase is to attach an amino acid to a tRNA, that can then interact with codons that identify its amino acid. Taking both similar acetylation function and amino acid motifs into consideration, 2 separate classes of aminoacyl-tRNA synthetases could be differentiated. Class I enzyme is normally monomeric and binds the tRNA acceptor stem from the minor groove. It adds amino acid to 2’-OH of the adenylate residue, moving it into the 3’-OH position. Meanwhile, Class II aminoacyl-tRNA synthetase is oligomeric and binds the tRNA acceptor stem from the major groove. The enzyme proceeds to add amino acid to the 3’-OH position directly. The aminoacyl-tRNA synthetases can distinguish between different tRNAs and this recognition doesn't follow the same pattern. An aminoacyl-tRNA synthetase recognizes a set of sequentinal elements and binds tRNA with the respective amino acid. Examples of these elements vary: 1 base in the anticodon, 1 of 3 base pairs in the acceptor stem and others. However, depending on the chirality of the amino acid, an aminoacyl-tRNA-synthase can actually disrupt the ester bond between D-amino acids and tRNA.
Nando's has been established in Malaysia since 1998. The chain is very popular in the country and Malaysia is Nando's third largest market after the United Kingdom and Australia. Nando's is well known for its effective advertising that celebrates or satirises contemporary local issues. As of August 2021, Nando's has 73 restaurants operating throughout Malaysia (with the exception of Perlis and Labuan); 27 in Selangor, 19 in Kuala Lumpur, two in Putrajaya, five in Penang, four in Johor, three in Malacca, three in Perak, three in Sarawak, two in Negeri Sembilan and Sabah and one each in Kedah, Kelantan, Pahang, Terengganu. Nando's has been established in Pakistan since 2001. As of August 2021, Nando's has 12 restaurants throughout Pakistan; five in Karachi, four in Lahore and one each in Islamabad, Faisalabad and Rawalpindi. In Singapore, Nando's opened its first restaurant on 9 May 2010; and as of August 2021 there were six outlets throughout the city of Singapore.
==== Polish ==== Alliance of Poles in America - Founded on September 22, 1895, in Ohio as Alliance of Poles. Added "of America" in 1914. Headquarters in Cleveland. Locals are called "Groups", regional groups "Circles", and the national structure is the "Central Body", which meets quadrennially. Membership is open to both sexes from the start. Now open to anyone 15–65, of good moral character, physically and mentally healthy, Polish or Lithuanian by birth or consanguinity. Has no ritual, but it does have an oath. Had 16,000 in the late 1960s, and 20,000 in 72 locals in 1979. Had 20,000 members in 1994. Federal Life Insurance of America - Founded in 1911 as a pressure group with the US Catholic church for Polish interests. Its original name was the Federation of Polish Catholic Laymen. The insurance aspect was added in 1913, and the name changed to the Federation of Poles in America. Became Federal Life Insurance of America in 1924. Local groups are called "Lodges"; in 1979 there were 28 lodges in 7 states. The national convention meets quadrennially. Poles or people of Polish descent are eligible. A women's division was added in 1940. There were 5,000 members in 1960, and 5,543 in 1979. There were 4,476 in 1994. Sent food and clothing to Poland and Polish refugees during World War II; aided the Ochronka Orphanage in Poland since the war; also supports International Folk Fair in Milwaukee. Polish Beneficial Association - Founded in 1899 in Philadelphia and headquartered there. Locals are called "groups". National convention meets quadrennially.
== Efficiency of bond-skipping == Different 2A peptides have different peptide-bond-skipping efficiencies, with T2A and P2A being the most efficient and F2A the least efficient. Therefore, up to 50% of F2A-linked proteins can in fact be produced as a fusion protein, which might cause some unpredictable outcomes, including a gain of function. One study reported that 2A sites cause the ribosome to fall off approximately 60% of the time, and that, together with ribosome read-through of about 10% for P2A and T2A, this results in reducing expression of the downstream peptide chain by about 70%. However, the level of drop-off detected in this study varied widely depending on the exact construct used, with some constructs showing little evidence of drop-off; furthermore, within a tri-cistronic transcript it reported a higher level of ribosome drop-off after one 2A sequence than after two 2As combined, which is at odds with a linear model of translation.
Sources: en.wikipedia.org
The amino acid sequence matches human growth hormone-releasing hormone, but the amino terminus carries a trans-3-hexenoyl group instead of a free amine. That single structural change chiefly affects enzymatic stability rather than receptor selectivity.
Growth hormone released from the pituitary stimulates IGF-1 production in the liver and other tissues, so circulating IGF-1 generally rises during exposure. The size of the rise varies between individuals and depends on baseline hormonal status and other concurrent factors.
Reported imaging studies focus on visceral adipose tissue, where reductions are more consistently observed across trials. Subcutaneous depots show smaller and less reproducible changes, so the two compartments should not be treated as equivalent.
No. It is a peptide that acts upstream of growth hormone release, while growth hormone is the hormone itself. The two differ in size, in receptor, and in how the body clears them.